Even though growth of a primary tumor and metastatic colonies derived from basal breast cancer cells is suppressed in response to GRHL2 depletion, the combination of reduced growth with aspects of EMT and enhanced motility does warrant caution with strategies aimed at decreasing expression of GRHL2 in basal breast cancer. Here, GRHL2 is linked to neoplasm.